Efficacy and safety of MK ‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open‐label clinical trial

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Philip D. Home DPhil , Raymond L. H. Lam PhD , Wendy L. Carofano PharmD , Gregory T. Golm PhD , Roy Eldor MD , Michael F. Crutchlow MD , Michael C. Marcos MS , Julio Rosenstock MD , Priscilla A. Hollander MD , Baptis Source Type: research